The effect of TRPV1 gene polymorphism on the development of progressive course of chronic obstructive pulmonary disease
https://doi.org/10.36604/1998-5029-2023-89-36-43
Abstract
Introduction. It is known that the course of chronic obstructive pulmonary disease (COPD) may vary depending on the rate of bronchial obstruction progression. It has been shown that TRPV1 channels play an important role in the formation of some pathological syndromes typical for COPD.
Aim. To study the effect of single nucleotide polymorphisms (SNPs) of TRPV1 gene on the rate of bronchial obstruction progression in COPD patients.
Materials and methods. We examined 103 patients with COPD, including 47 with rapid progression of bronchial obstruction (decrease in FEV1≥50 ml/year). SNPs rs460716, rs222749, rs222747, and rs8065080 were genotyped by LATE-PCR.
Results. We established that rs460716 SNP had a significant effect on the development of progressive bronchial obstruction in COPD. The CC+TT genotypes were more common among patients with progressive disease (48.9% versus 23.2%), while the heterozygous genotype was protective (p=0.006). Differences remained significant after adjusting for sex, age, pack-year index and baseline FEV1 (OR 3.2; 95%CI [1.32; 7.57], p=0.009).
Conclusion. The obtained results indicate a negative influence of the homozygous genotypes carriage for TRPV1 rs460716 SNP on the course of COPD.
About the Authors
D. A. GassanRussian Federation
Dina A. Gassan, PhD (Med.), Staff Scientist, Laboratory of Molecular and Translational Research
22 Kalinina Str., Blagoveshchensk, 675000
D. E. Naumov
Russian Federation
Denis E. Naumov, PhD (Med.), Head of Laboratory of Molecular and Translational Research
22 Kalinina Str., Blagoveshchensk, 675000
O. O. Kotova
Russian Federation
Olesya O. Kotova, PhD (Med.), Junior Staff Scientist, Laboratory of Molecular and Translational Research
22 Kalinina Str., Blagoveshchensk, 675000
I. Yu. Sugaylo
Russian Federation
Ivana Yu. Sugaylo, PhD (Med.), Junior Staff Scientist, Laboratory of Molecular and Translational Research
22 Kalinina Str., Blagoveshchensk, 675000
E. G. Sheludko
Russian Federation
Elizaveta G. Sheludko, PhD (Med.), Staff Scientist, Laboratory of Molecular and Translational Research
22 Kalinina Str., Blagoveshchensk, 675000
E. Yu. Afanas’eva
Russian Federation
Evgeniya Yu. Afanas’eva, PhD (Med.), Junior Staff Scientist, Laboratory of Molecular and Translational Research
22 Kalinina Str., Blagoveshchensk, 675000
Y. G. Gorchakova
Russian Federation
Yana G. Gorchakova, Research Laboratory Assistant, Laboratory of Molecular and Translational Research
22 Kalinina Str., Blagoveshchensk, 675000
References
1. Lee H.W., Lee J.K., Lee M.G., Shin K.C., Ra S.W., Kim T.H., Hwang Y.I., Jung K.S., Yoo K.H., Kim D.K. Risk Factors of Rapid FEV1 Decline in a Real-World Chronic Obstructive Pulmonary Disease Cohort. Respiration 2022; 101(12):1078–1087. https://doi.org/10.1159/000525871
2. Wang J.M., Labaki W.W., Murray S., Martinez F.J., Curtis J.L., Hoffman E.A., Ram S., Bell A.J., Galban C.J., Han M.K., Hatt C. Machine learning for screening of at-risk, mild and moderate COPD patients at risk of FEV1 decline: results from COPDGene and SPIROMICS. Front. Physiol. 2023; 14:1144192. https://doi.org/10.3389/fphys.2023.1144192
3. DiLillo K.M., Norman K.C., Freeman C.M., Christenson S.A., Alexis N.E., Anderson W.H., Barjaktarevic I.Z., Barr R.G., Comellas A.P., Bleecker E.R., Boucher R.C., Couper D.J., Criner G.J., Doerschuk C.M., Wells J.M., Han M.K., Hoffman E.A., Hansel N.N., Hastie A.T., Kaner R.J., Krishnan J.A., Labaki W.W., Martinez F.J., Meyers D.A., O'Neal W.K., Ortega V.E., Paine R. 3rd, Peters S.P., Woodruff P.G., Cooper C.B., Bowler R.P., Curtis J.L., Arnold K.B.; SPIROMICS investigators. A blood and bronchoalveolar lavage protein signature of rapid FEV1 decline in smoking-associated COPD. Sci. Rep. 2023; 13(1):8228. https://doi.org/10.1038/s41598-023-32216-0.
4. Sugaylo I.Yu., Gassan D.A., Kotova O.O., Naumov D.E., Gorchakova Y.G., Sheludko E.G., Afanas'eva E.Yu. [The influence of TRPM8 polymorphism on the progression of bronchial obstruction in patients with chronic obstructive pulmonary disease]. Bûlleten' fiziologii i patologii dyhaniâ = Bulletin Physiology and Pathology of Respiration 2022; (86):15– 23 (in Russian). https://doi.org/10.36604/1998-5029-2022-86-15-23
5. Dumitrache M.D., Jieanu A.S., Scheau C., Badarau I.A., Popescu G.D.A., Caruntu A., Costache D.O., Costache R.S., Constantin C., Neagu M., Caruntu C. Comparative effects of capsaicin in chronic obstructive pulmonary disease and asthma (Review). Exp. Ther. Med. 2021; 22(3):917. https://doi.org/10.3892/etm.2021.10349
6. Lian Z., Qi H., Liu X., Zhang Y., Xu R., Yang X., Zeng Y., Li J. Ambient ozone, and urban PM2.5 co-exposure, aggravate allergic asthma via transient receptor potential vanilloid 1-mediated neurogenic inflammation. Ecotoxicol. Environ. Saf. 2022; 243:114000. https://doi.org/10.1016/j.ecoenv.2022.114000
7. Terada K., Muro S., Ohara T., Haruna A., Marumo S., Kudo M., Ogawa E., Hoshino Y., Hirai T., Niimi A., Mishima M. Cough-reflex sensitivity to inhaled capsaicin in COPD associated with increased exacerbation frequency. Respirology 2009; 14(8):1151–1155. https://doi.org/10.1111/j.1440-1843.2009.01620.x
8. Baxter M., Eltom S., Dekkak B., Yew-Booth L., Dubuis E.D., Maher S.A., Belvisi M.G., Birrell M.A. Role of transient receptor potential and pannexin channels in cigarette smoke-triggered ATP release in the lung. Thorax 2014; 69(12):1080–1089. https://doi.org/10.1136/thoraxjnl-2014-205467
9. Kanemitsu Y., Kurokawa R., Akamatsu T., Fukumitsu K., Fukuda S., Ito Y., Takeda N., Nishiyama H., Ito K., Tajiri T., Mori Y., Uemura T., Ohkubo H., Takemura M., Maeno K., Oguri T., Shirai T., Niimi A. Decreased capsaicin cough reflex sensitivity predicts hospitalisation due to COPD. BMJ Open Respir. Res. 2023; 10(1):e001283. https://doi.org/10.1136/bmjresp-2022-001283
10. Xiong M., Guo M., Huang D., Li J., Zhou Y. TRPV1 genetic polymorphisms and risk of COPD or COPD combined with PH in the Han Chinese population. Cell Cycle 2020; 19(22):3066–3073. https://doi.org/10.1080/15384101.2020.1831246
11. Li T., Wang G., Hui V.C.C., Saad D., de Sousa Valente J., La Montanara P., Nagy I. TRPV1 feed-forward sensitisation depends on COX2 upregulation in primary sensory neurons. Sci. Rep. 2021; 11(1):3514. https://doi.org/10.1038/s41598-021-82829-6
12. Starowicz K., Nigam S., Di Marzo V. Biochemistry and pharmacology of endovanilloids. Pharmacol. Ther. 2007; 114(1):13–33. https://doi.org/10.1016/j.pharmthera.2007.01.005
13. Toy H.I., Yildiz A.B., Tasdemir Kahraman D., Ilhan S., Dikensoy O., Bayram H. Capsaicin suppresses ciliary function, while inducing permeability in bronchial epithelial cell cultures of COPD patients. Front. Pharmacol. 2022; 13:996046. https://doi.org/10.3389/fphar.2022.996046
14. Okamoto N., Okumura M., Tadokoro O., Sogawa N., Tomida M., Kondo E. Effect of single-nucleotide polymorphisms in TRPV1 on burning pain and capsaicin sensitivity in Japanese adults. Mol. Pain 2018; 14:1744806918804439. https://doi.org/10.1177/1744806918804439
15. Cantero-Recasens G., Gonzalez J.R., Fandos C., Duran-Tauleria E., Smit L.A., Kauffmann F., Antó J.M., Valverde M.A. Loss of function of transient receptor potential vanilloid 1 (TRPV1) genetic variant is associated with lower risk of active childhood asthma. J. Biol. Chem. 2010; 285(36):27532–27535. https://doi.org/10.1074/jbc.C110.159491
16. Birrell M.A., Bonvini S.J., Dubuis E., Maher S.A., Wortley M.A., Grace M.S., Raemdonck K., Adcock J.J., Belvisi M.G. Tiotropium modulates transient receptor potential V1 (TRPV1) in airway sensory nerves: A beneficial off-target effect? J. Allergy Clin. Immunol. 2014; 133(3):679–687.e9. https://doi.org/10.1016/j.jaci.2013.12.003.
Review
For citations:
Gassan D.A., Naumov D.E., Kotova O.O., Sugaylo I.Yu., Sheludko E.G., Afanas’eva E.Yu., Gorchakova Y.G. The effect of TRPV1 gene polymorphism on the development of progressive course of chronic obstructive pulmonary disease. Bulletin Physiology and Pathology of Respiration. 2023;(89):36-43. (In Russ.) https://doi.org/10.36604/1998-5029-2023-89-36-43






















